Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pumps, Electronic Autoinjectors, Electronic Injection Pumps, and Electronic Inhalers), By Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD, and Other Indications), and By Region – Global Opportunities & Forecast, 2020-2027
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global Electronic Drug Delivery Systems Market- Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global Electronic Drug Delivery Systems Market Revenue Forecast till 2027
5. Global Electronic Drug Delivery Systems Market by Type Revenue Forecast till 2027
5.1. Electronic Wearable Infusion Pumps
5.2. Electronic Autoinjectors
5.3. Electronic Injection Pens
5.4. Electronic Inhalers
6. Global Electronic Drug Delivery Systems Market by Indication Revenue Forecast till 2027
6.1. Diabetes
6.2. Multiple Sclerosis
6.3. Cardiovascular Disease
6.4. Asthma & COPD
6.5. Other Indications
7. Global Electronic Drug Delivery Systems Market by Region Forecast till 2027
7.1. North America Electronic Drug Delivery Systems Market Revenue Forecast till 2027
(Option 1: As a part of the free 25% customization)
7.1.1. North America Electronic Drug Delivery Systems Market by Type
7.1.1.1. Electronic Wearable Infusion Pumps
7.1.1.2. Electronic Autoinjectors
7.1.1.3. Electronic Injection Pens
7.1.1.4. Electronic Inhalers
7.1.2. North America Electronic Drug Delivery Systems Market by Indication
7.1.2.1. Diabetes
7.1.2.2. Multiple Sclerosis
7.1.2.3. Cardiovascular Disease
7.1.2.4. Asthma & COPD
7.1.2.5. Other Indications
7.1.3. US Electronic Drug Delivery Systems Market All-Up
7.1.4. Canada Electronic Drug Delivery Systems Market All-Up
7.2. Europe Electronic Drug Delivery Systems Market Revenue Forecast till 2027
(Option 2: As a part of the free 25% customization)
7.2.1. Europe Electronic Drug Delivery Systems Market by Type
7.2.1.1. Electronic Wearable Infusion Pumps
7.2.1.2. Electronic Autoinjectors
7.2.1.3. Electronic Injection Pens
7.2.1.4. Electronic Inhalers
7.2.2. Europe Electronic Drug Delivery Systems Market by Indication
7.2.2.1. Diabetes
7.2.2.2. Multiple Sclerosis
7.2.2.3. Cardiovascular Disease
7.2.2.4. Asthma & COPD
7.2.2.5. Other Indications
7.2.3. UK Electronic Drug Delivery Systems Market All-Up
7.2.4. Germany Electronic Drug Delivery Systems Market All-Up
7.2.5. France Electronic Drug Delivery Systems Market All-Up
7.2.6. Spain Electronic Drug Delivery Systems Market All-Up
7.2.7. Rest of Europe Electronic Drug Delivery Systems Market All-Up
7.3. Asia-Pacific Electronic Drug Delivery Systems Market Revenue Forecast till 2027
(Option 3: As a part of the free 25% customization)
7.3.1. Asia-Pacific Electronic Drug Delivery Systems Market by Type
7.3.1.1. Electronic Wearable Infusion Pumps
7.3.1.2. Electronic Autoinjectors
7.3.1.3. Electronic Injection Pens
7.3.1.4. Electronic Inhalers
7.3.2. Asia-Pacific Electronic Drug Delivery Systems Market by Indication
7.3.2.1. Diabetes
7.3.2.2. Multiple Sclerosis
7.3.2.3. Cardiovascular Disease
7.3.2.4. Asthma & COPD
7.3.2.5. Other Indications
7.3.3. China Electronic Drug Delivery Systems Market All-Up
7.3.4. India Electronic Drug Delivery Systems Market All-Up
7.3.5. Japan Electronic Drug Delivery Systems Market All-Up
7.3.6. Rest of APAC Electronic Drug Delivery Systems Market All-Up
7.4. RoW Electronic Drug Delivery Systems Market Revenue Forecast till 2027
(Option 4: As a part of the free 25% customization)
7.4.1. RoW Electronic Drug Delivery Systems Market by Type
7.4.1.1. Electronic Wearable Infusion Pumps
7.4.1.2. Electronic Autoinjectors
7.4.1.3. Electronic Injection Pens
7.4.1.4. Electronic Inhalers
7.4.2. RoW Electronic Drug Delivery Systems Market by Indication
7.4.2.1. Diabetes
7.4.2.2. Multiple Sclerosis
7.4.2.3. Cardiovascular Disease
7.4.2.4. Asthma & COPD
7.4.2.5. Other Indications
7.4.3. Brazil Electronic Drug Delivery Systems Market All-Up
7.4.4. South Africa Electronic Drug Delivery Systems Market All-Up
7.4.5. Saudi Arabia Electronic Drug Delivery Systems Market All-Up
7.4.6. UAE Electronic Drug Delivery Systems Market All-Up
7.4.7. Rest of world (remaining countries of the LAMEA region) Electronic Drug Delivery Systems Market All-Up
8. Competitive Landscape Analysis
8.1. Porter’s Five Forces Analysis
8.2. Industry – Competitive Landscape
8.3. Market Presence (Intensity Mapping)
8.4. Key Strategic Market Developments
9. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
9.1. Merck KGaA
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Footprint & Employee Strength
9.1.4. Product Offerings
9.1.5. Financials
9.1.6. Key Company Developments
9.2. Insulet Corporation
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Footprint & Employee Strength
9.2.4. Product Offerings
9.2.5. Financials
9.2.6. Key Company Developments
9.3. Bayer AG
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Footprint & Employee Strength
9.3.4. Product Offerings
9.3.5. Financials
9.3.6. Key Company Developments
9.4. Medtronic
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Footprint & Employee Strength
9.4.4. Product Offerings
9.4.5. Financials
9.4.6. Key Company Developments
9.5. United Therapeutics Corporation
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Footprint & Employee Strength
9.5.4. Product Offerings
9.5.5. Financials
9.5.6. Key Company Developments
9.6. Companion Medical
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Footprint & Employee Strength
9.6.4. Product Offerings
9.6.5. Financials
9.6.6. Key Company Developments
9.7. Novo Nordisk A/S
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Footprint & Employee Strength
9.7.4. Product Offerings
9.7.5. Financials
9.7.6. Key Company Developments
9.8. F. Hoffmann-La Roche Ltd
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Footprint & Employee Strength
9.8.4. Product Offerings
9.8.5. Financials
9.8.6. Key Company Developments
9.9. Amgen Inc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Footprint & Employee Strength
9.9.4. Product Offerings
9.9.5. Financials
9.9.6. Key Company Developments
9.10. AstraZeneca
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Footprint & Employee Strength
9.10.4. Product Offerings
9.10.5. Financials
9.10.6. Key Company Developments
10. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
- Published Date: Jan - 2020
- Report Format: Excel/PPT
- Report Code: UP361A-00-0620
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pumps, Electronic Autoinjectors, Electronic Injection Pumps, and Electronic Inhalers), By Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD, and Other Indications), and By Region – Global Opportunities & Forecast, 2020-2027
$ 4,499.00 – $ 6,649.00
Why GMI Research
